Fenix Innovation Group
Clinical trials sponsored by Fenix Innovation Group, explained in plain language.
-
Cannabis extract trial aims to ease autism symptoms in kids
Symptom relief Not yet recruitingThis study tests whether a full-spectrum cannabis plant extract called NTI164 can help reduce core autism symptoms like social difficulties and repetitive behaviors. About 98 children and young adults aged 6 to 25 with moderate to severe autism will receive either NTI164 or a pla…
Phase: PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated May 17, 2026 11:48 UTC
-
Cannabis extract shows promise for rare genetic disorder in new trial
Symptom relief Not yet recruitingThis study tests a cannabis plant extract with very low THC (NTI164) in 40 females aged 4-25 with Rett syndrome, a rare genetic condition causing severe physical and mental challenges. Participants will receive either NTI164 or a placebo, then switch after a period. The goal is t…
Phase: PHASE2, PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC